Birdwatch Note
2024-09-21 11:26:53 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Alexis suffers from paroxysmal nocturnal hemoglobinuria (PNH), whereby a gene called PIGA in one stem cell mutates or changes into an abnormal stem cell causing a cascading series of medical issues. There is no link between vaccines and PNH. https://my.clevelandclinic.org/health/diseases/22871-paroxysmal-nocturnal-hemoglobinuria
Written by 87862316201459CCE48B6F17413B86E3A1ADA24CD99D30D6D7BE90164C8A678A
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1837361230807245159
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1837453442039566522
- noteId - 1837453442039566522
- participantId -
- noteAuthorParticipantId - 87862316201459CCE48B6F17413B86E3A1ADA24CD99D30D6D7BE90164C8A678A Participant Details
- createdAtMillis - 1726918013473
- tweetId - 1837361230807245159
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 1
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Alexis suffers from paroxysmal nocturnal hemoglobinuria (PNH), whereby a gene called PIGA in one stem cell mutates or changes into an abnormal stem cell causing a cascading series of medical issues. There is no link between vaccines and PNH. https://my.clevelandclinic.org/health/diseases/22871-paroxysmal-nocturnal-hemoglobinuria
Note Ratings
| rated at | rated by | |
| 2024-09-23 15:47:25 -0500 | Rating Details | |
| 2024-09-22 15:38:53 -0500 | Rating Details | |
| 2024-09-22 15:13:32 -0500 | Rating Details | |
| 2024-09-22 13:24:07 -0500 | Rating Details | |
| 2024-09-22 10:55:46 -0500 | Rating Details | |
| 2024-09-22 08:34:31 -0500 | Rating Details | |
| 2024-09-22 05:56:57 -0500 | Rating Details | |
| 2024-09-22 05:44:18 -0500 | Rating Details | |
| 2024-09-22 05:15:18 -0500 | Rating Details | |
| 2024-09-22 04:28:12 -0500 | Rating Details | |
| 2024-09-22 02:49:42 -0500 | Rating Details | |
| 2024-09-22 02:49:05 -0500 | Rating Details | |
| 2024-09-22 01:08:49 -0500 | Rating Details | |
| 2024-09-22 00:50:25 -0500 | Rating Details | |
| 2024-09-22 00:20:10 -0500 | Rating Details | |
| 2024-09-22 00:12:14 -0500 | Rating Details | |
| 2024-09-22 00:03:53 -0500 | Rating Details | |
| 2024-09-21 23:30:09 -0500 | Rating Details | |
| 2024-09-21 22:52:20 -0500 | Rating Details | |
| 2024-09-21 21:30:40 -0500 | Rating Details | |
| 2024-09-21 21:08:00 -0500 | Rating Details | |
| 2024-09-21 20:39:36 -0500 | Rating Details | |
| 2024-09-21 20:32:44 -0500 | Rating Details | |
| 2024-09-21 20:27:08 -0500 | Rating Details | |
| 2024-09-21 20:19:25 -0500 | Rating Details | |
| 2024-09-21 19:40:10 -0500 | Rating Details | |
| 2024-09-21 19:32:55 -0500 | Rating Details | |
| 2024-09-21 19:03:13 -0500 | Rating Details | |
| 2024-09-21 17:54:45 -0500 | Rating Details | |
| 2024-09-21 17:23:07 -0500 | Rating Details | |
| 2024-09-21 16:43:59 -0500 | Rating Details | |
| 2024-09-21 16:29:01 -0500 | Rating Details | |
| 2024-09-21 16:07:49 -0500 | Rating Details | |
| 2024-09-21 15:20:48 -0500 | Rating Details | |
| 2024-09-21 15:08:17 -0500 | Rating Details | |
| 2024-09-21 15:06:42 -0500 | Rating Details | |
| 2024-09-21 14:55:15 -0500 | Rating Details | |
| 2024-09-21 13:33:10 -0500 | Rating Details | |
| 2024-09-21 12:52:38 -0500 | Rating Details | |
| 2024-09-21 12:49:00 -0500 | Rating Details | |
| 2024-09-21 12:36:25 -0500 | Rating Details | |
| 2024-09-21 11:42:19 -0500 | Rating Details | |
| 2024-09-21 11:09:34 -0500 | Rating Details | |
| 2024-09-21 11:03:19 -0500 | Rating Details | |
| 2024-09-21 11:01:32 -0500 | Rating Details | |
| 2024-09-21 10:55:09 -0500 | Rating Details | |
| 2024-09-21 10:53:21 -0500 | Rating Details | |
| 2024-09-21 10:52:24 -0500 | Rating Details | |
| 2024-09-21 10:41:31 -0500 | Rating Details | |
| 2024-09-21 10:36:20 -0500 | Rating Details | |
| 2024-09-21 10:26:48 -0500 | Rating Details | |
| 2024-09-21 10:18:29 -0500 | Rating Details | |
| 2024-09-21 10:02:48 -0500 | Rating Details | |
| 2024-09-21 10:01:31 -0500 | Rating Details | |
| 2024-09-21 09:44:54 -0500 | Rating Details | |
| 2024-09-21 09:37:28 -0500 | Rating Details | |
| 2024-09-21 09:21:51 -0500 | Rating Details | |
| 2024-09-21 09:17:07 -0500 | Rating Details | |
| 2024-09-21 09:10:29 -0500 | Rating Details | |
| 2024-09-21 09:06:59 -0500 | Rating Details | |
| 2024-09-21 08:46:41 -0500 | Rating Details | |
| 2024-09-21 08:44:38 -0500 | Rating Details | |
| 2024-09-21 08:38:19 -0500 | Rating Details | |
| 2024-09-21 08:37:37 -0500 | Rating Details | |
| 2024-09-21 08:33:50 -0500 | Rating Details | |
| 2024-09-21 08:22:53 -0500 | Rating Details | |
| 2024-09-21 08:22:52 -0500 | Rating Details | |
| 2024-09-21 08:14:57 -0500 | Rating Details | |
| 2024-09-21 07:58:36 -0500 | Rating Details | |
| 2024-09-21 07:55:51 -0500 | Rating Details | |
| 2024-09-21 07:55:37 -0500 | Rating Details | |
| 2024-09-21 07:53:30 -0500 | Rating Details | |
| 2024-09-21 07:34:31 -0500 | Rating Details | |
| 2024-09-21 07:34:04 -0500 | Rating Details | |
| 2024-09-21 07:32:22 -0500 | Rating Details | |
| 2024-09-21 07:30:46 -0500 | Rating Details | |
| 2024-09-21 07:14:39 -0500 | Rating Details | |
| 2024-09-21 06:53:18 -0500 | Rating Details | |
| 2024-09-21 06:50:21 -0500 | Rating Details | |
| 2024-11-16 14:36:22 -0600 | Rating Details | |
| 2024-12-03 07:58:59 -0600 | Rating Details |